198 results
Page 5 of 10
424B5
0rl pcshczwcf8
6 May 22
Prospectus supplement for primary offering
7:15am
8-K
EX-10.1
yqx rb5vna
6 May 22
Entry into a Material Definitive Agreement
6:02am
8-K
EX-4.1
sdvbk0 125m6wu
6 May 22
Entry into a Material Definitive Agreement
6:02am
424B5
fqq5gm9spseur
9 Feb 22
Prospectus supplement for primary offering
4:08pm
8-K
4m3eyia
6 Dec 21
Aeglea BioTherapeutics Announces Achievement of Primary Endpoint in Phase 3 Study of Pegzilarginase in Patients with Arginase 1 Deficiency
6:30am